Skip to main content
    • Aa
    • Aa

The pathogenesis of Niemann–Pick type C disease: a role for autophagy?

  • Chris D. Pacheco (a1) and Andrew P. Lieberman (a1) (a2)

Niemann–Pick type C disease (NPC) is a sphingolipid-storage disorder that results from inherited deficiencies of intracellular lipid-trafficking proteins, and is characterised by an accumulation of cholesterol and glycosphingolipids in late endosomes and lysosomes. Patients with this disorder develop progressive neurological impairment that often begins in childhood, is ultimately fatal and is currently untreatable. How impaired lipid trafficking leads to neurodegeneration is largely unknown. Here we review NPC clinical features and biochemical defects, and discuss model systems used to study this disorder. Recent studies have established that NPC is associated with an induction of autophagy, a regulated and evolutionarily conserved process by which cytoplasmic proteins are sequestered within autophagosomes and targeted for degradation. This pathway enables recycling of limited or damaged macromolecules to promote cell survival. However, in other instances, robust activation of autophagy leads to cell stress and programmed cell death. We summarise evidence showing that autophagy induction and flux are increased in NPC by signalling through a complex of the class III phosphoinositide 3-kinase and beclin-1. We propose that an imbalance between induction and flux through the autophagic pathway contributes to cell stress and neuronal loss in NPC and related sphingolipid-storage disorders, and discuss potential therapeutic strategies for modulating activity of this pathway.

Corresponding author
*Corresponding author: Andrew P. Lieberman, Department of Pathology, University of Michigan Medical School, 3500 MSRB 1, 1150 W. Medical Center Dr., Ann Arbor, MI 48109, USA. Tel: +1 734 647 4623; Fax: +1 734 615 3441; E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 P.J. Meikle (1999) Prevalence of lysosomal storage disorders. JAMA 281, 249-254

2 D.C. German (2002) Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 109, 437-450

3 S.C. Patel (1999) Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann-Pick type C disease. Proc Natl Acad Sci U S A 96, 1657-1662

4 M.T. Vanier and G. Millat (2003) Niemann-Pick disease type C. Clin Genet 64, 269-281

5 J.J. Higgins (1992) A clinical staging classification for type C Niemann-Pick disease. Neurology 42, 2286-2290

6 B. Karten (2002) Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons. J Neurochem 83, 1154-1163

7 B. Karten (2003) Trafficking of cholesterol from cell bodies to distal axons in Niemann Pick C1-deficient neurons. J Biol Chem 278, 4168-4175

8 P.C. Reid , S. Sugii and T.Y. Chang (2003) Trafficking defects in endogenously synthesized cholesterol in fibroblasts, macrophages, hepatocytes, and glial cells from Niemann-Pick type C1 mice. J Lipid Res 44, 1010-1019

9 E.D. Carstea (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277, 228-231

10 S. Naureckiene (2000) Identification of HE1 as the second gene of Niemann-Pick C disease. Science 290, 2298-2301

12 T. Yamamoto (2000) Genotype-phenotype relationship of Niemann-Pick disease type C: a possible correlation between clinical onset and levels of NPC1 protein in isolated skin fibroblasts. J Med Genet 37, 707-712

13 J. Imrie (2002) Niemann-Pick disease type C in adults. J Inherit Metab Dis 25, 491-500

14 J.C. Turpin , M. Masson and N. Baumann (1991) Clinical aspects of Niemann-Pick type C disease in the adult. Dev Neurosci 13, 304-306

16 M. Sevin (2007) The adult form of Niemann-Pick disease type C. Brain 130, 120-133

17 G. Millat (2001) Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. Am J Hum Genet 69, 1013-1021

18 S.U. Walkley and K. Suzuki (2004) Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta 1685, 48-62

19 I.A. Auer (1995) Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol 90, 547-551

20 J.M. Dietschy and S.D. Turley (2002) Control of cholesterol turnover in the mouse. J Biol Chem 277, 3801-3804

21 G. Quan (2003) Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 146, 87-98

22 J. Herz and H.H. Bock (2002) Lipoprotein receptors in the nervous system. Annu Rev Biochem 71, 405-434

24 J.M. Dietschy and S.D. Turley (2001) Cholesterol metabolism in the brain. Curr Opin Lipidol 12, 105-112

25 D.H. Mauch (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357

26 R.E. Pagano (2003) Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Philos Trans R Soc Lond B Biol Sci 358, 885-891

27 X. Fu (2001) 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 276, 38378-38387

28 B.A. Janowski (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383, 728-731

29 D.S. Ory (2000) Niemann-Pick type C: a disorder of cellular cholesterol trafficking. Biochim Biophys Acta 1529, 331-339

30 L. Liscum , R.M. Ruggiero and J.R. Faust (1989) The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J Cell Biol 108, 1625-1636

32 K.M. Wojtanik and L. Liscum (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 278, 14850-14856

33 J.E. Vance (2006) Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett 580, 5518-5524

34 G.H. Thomas (1989) Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media. J Inherit Metab Dis 12, 139-151

35 M.E. Higgins (1999) Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab 68, 1-13

36 E.B. Neufeld (1999) The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 274, 9627-9635

37 H. Watari (1999) Mutations in the leucine zipper motif and sterol-sensing domain inactivate the Niemann-Pick C1 glycoprotein. J Biol Chem 274, 21861-21866

38 H. Runz (2008) NPC-db, a Niemann-Pick type C disease gene variation database. Hum Mutat 29, 345-350

39 K. Malathi (2004) Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution. J Cell Biol 164, 547-556

40 M. Sym , M. Basson and C. Johnson (2000) A model for niemann-pick type C disease in the nematode Caenorhabditis elegans. Curr Biol 10, 527-530

41 X. Huang (2005) A Drosophila model of the Niemann-Pick type C lysosome storage disease: dnpc1a is required for molting and sterol homeostasis. Development 132, 5115-5124

44 M. Kuwamura (1993) Type C Niemann-Pick disease in a boxer dog. Acta Neuropathol 85, 345-348

45 A.L. Mutka (2004) Secretion of sterols and the NPC2 protein from primary astrocytes. J Biol Chem 279, 48654-48662

46 N. Friedland (2003) Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc Natl Acad Sci U S A 100, 2512-2517

47 D.C. Ko (2003) The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels. Proc Natl Acad Sci U S A 100, 2518-2525

48 D.E. Sleat (2004) Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A 101, 5886-5891

49 S.K. Loftus (1997) Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277, 232-235

51 V.M. Rimkunas (2008) In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease. Hepatology 47, 1504-1512

52 S.U. Walkley (1995) Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity. Neuroscience 68, 1027-1035

53 C. Xie (2000) Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased. J Neuropathol Exp Neurol 59, 1106-1117

54 M. Zervas , K. Dobrenis and S.U. Walkley (2001) Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 60, 49-64

55 S. Takikita (2004) Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse. J Neuropathol Exp Neurol 63, 660-673

56 Y. Higashi (1993) Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol 85, 175-184

57 W. Yu (2005) Neurodegeneration in heterozygous Niemann-Pick type C1 (NPC1) mouse: implication of heterozygous NPC1 mutations being a risk for tauopathy. J Biol Chem 280, 27296-27302

58 M.C. Gondre-Lewis , R. McGlynn and S.U. Walkley (2003) Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent. Curr Biol 13, 1324-1329

59 T. Cox (2000) Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355, 1481-1485

60 M. Zervas (2001) Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr Biol 11, 1283-1287

61 M.C. Patterson (2007) Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol 6, 765-772

62 S.H. Mellon (2007) Neurosteroid regulation of central nervous system development. Pharmacol Ther 116, 107-124

63 L.D. Griffin (2004) Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 10, 704-711

64 S.J. Langmade (2006) Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A 103, 13807-13812

65 A. Frolov (2001) Cholesterol overload promotes morphogenesis of a Niemann-Pick C (NPC)-like compartment independent of inhibition of NPC1 or HE1/NPC2 function. J Biol Chem 276, 46414-46421

66 J.J. Repa (2007) Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J Neurosci 27, 14470-14480

67 D.C. Ko (2005) Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease. PLoS Genet 1, 81-95

69 D.J. Klionsky (2003) A unified nomenclature for yeast autophagy-related genes. Dev Cell 5, 539-545

70 Z. Xie and D.J. Klionsky (2007) Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9, 1102-1109

71 Y. Ohsumi and N. Mizushima (2004) Two ubiquitin-like conjugation systems essential for autophagy. Semin Cell Dev Biol 15, 231-236

72 Y. Kabeya (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19, 5720-5728

73 I. Tanida , T. Ueno and E. Kominami (2004) Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J Biol Chem 279, 47704-47710

74 I. Tanida (2005) Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1, 84-91

75 D.J. Klionsky and S.D. Emr (2000) Autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721

76 T. Noda and Y. Ohsumi (1998) Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem 273, 3963-3966

77 A. Yamamoto , M.L. Cremona and J.E. Rothman (2006) Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172, 719-731

78 R.A. Nixon (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120, 4081-4091

79 T. Pan (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain, Jan 10 [Epub ahead of print]

80 B. Ravikumar (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36, 585-595

81 K. Kiselyov (2007) Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 3, 259-262

82 A. Williams (2006) Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 76, 89-101

83 A. Kuma (2004) The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036

84 M. Komatsu (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884

85 S. Shimizu (2004) Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6, 1221-1228

86 T. Shintani and D.J. Klionsky (2004) Autophagy in health and disease: a double-edged sword. Science 306, 990-995

87 G. Liao (2007) Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1−/−mouse brain. Am J Pathol 171, 962-975

88 C.D. Pacheco , R. Kunkel and A.P. Lieberman (2007) Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum Mol Genet 16, 1495-1503

89 J. Cheng (2006) Cholesterol depletion induces autophagy. Biochem Biophys Res Commun 351, 246-252

90 P. Lajoie (2005) The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies. J Cell Sci 118, 1991-2003

91 B. Levine and G. Kroemer (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42

93 S. Vergarajauregui (2008) Autophagic dysfunction in mucolipidosis type IV patients. Hum Mol Genet, Jun 11 (Epub ahead of print]

94 C. Settembre (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17, 119-129

95 Y. Cao (2006) Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J Biol Chem 281, 20483-20493

96 M. Beck (2007) New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet 121, 1-22

97 Y.S. Hsu (1999) Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation. Bone Marrow Transplant 24, 103-107

98 M.L. Escolar (2005) Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 352, 2069-2081

99 M.C. Patterson (1993) The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology 43, 61-64

100 M. Sylvain (1994) Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr Neurol 10, 228-232

101 M. Jeyakumar (2001) Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood 97, 327-329

102 A. Gaumann , H.J. Schlitt and E.K. Geissler (2008) Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin. Transpl Int 21, 207-217

N. Mizushima (2008) Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 5
Total number of PDF views: 32 *
Loading metrics...

Abstract views

Total abstract views: 425 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 28th June 2017. This data will be updated every 24 hours.